Dr. Martens plc (LON:DOCS)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 63.40
-0.40 (-0.63%)
Nov 11, 2026, 9:10 AM GMT
Dr. Martens Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Dr. Martens stock has a consensus rating of "Buy" and an average price target of 95p. The average 1-year stock price forecast is 50.11% higher than the current stock price, while the lowest is 60p (-5.36%) and the highest is 141p (+122.40%).
Price Target: 95p (+50.11%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Dr. Martens stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Downgrades 75p → 60p | Sell | Downgrades | 75p → 60p | -5.36% | Nov 2, 2026 |
| RBC Capital | RBC Capital | Hold Maintains 100p | Hold | Maintains | 100p | +57.73% | Oct 29, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 15, 2026 |
| Berenberg Bank | Berenberg Bank | Buy Reiterates 110p | Buy | Reiterates | 110p | +73.50% | Oct 9, 2026 |
| Peel Hunt | Peel Hunt | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 20, 2026 |
Financial Forecast
Revenue This Year
778.35M
from 764.90M
Increased by 1.76%
Revenue Next Year
816.29M
from 778.35M
Increased by 4.87%
EPS This Year
0.05
from 0.04
Increased by 20.78%
EPS Next Year
0.06
from 0.05
Increased by 21.81%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is GBP.